4-butyrolactone has been researched along with Neuroleptic Malignant Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blayac, JP; Boulenger, JP; Capdevielle, D; Deddouche, C; Eiden, C; Peyrière, H | 1 |
1 other study(ies) available for 4-butyrolactone and Neuroleptic Malignant Syndrome
Article | Year |
---|---|
Neuroleptic malignant syndrome-like reaction precipitated by antipsychotics in a patient with gamma-butyrolactone withdrawal.
Topics: 4-Butyrolactone; Adult; Antipsychotic Agents; Clonazepam; Diagnosis, Differential; Drug Evaluation, Preclinical; Drug Therapy, Combination; Female; Hallucinations; Humans; Infusions, Intravenous; Injections, Intramuscular; Loxapine; Neuroleptic Malignant Syndrome; Psychomotor Agitation; Solvents; Substance Withdrawal Syndrome; Substance-Related Disorders | 2011 |